Information Provided By:
Fly News Breaks for May 12, 2016
AMRN
May 12, 2016 | 07:05 EDT
Jefferies analyst Hugo Ong assumed coverage of Amarin with a Buy rating and $3.50 price target. Ooff-label Vascepa promotion in mixed dyslipidemia may be "beginning to bear fruit," Ong tells investors in a research note.
News For AMRN From the Last 2 Days
There are no results for your query AMRN